Why the study?
Does EVAR improve clinical outcomes and cost-effectiveness compared to OSR in high and low risk patients with AAA > 5.5 cm?
Does EVAR improve clinical outcomes and cost-effectiveness compared to OSR in high and low risk patients with AAA > 5.5 cm?
EVAR has similar clinical effectiveness but is more expensive than open surgical repair for low-risk patients with AAA > 5.5 cm.
Answers are grounded in this paper and cite their sources.
EVAR should not supplant OSR in low-risk AAA patients given absent cost-effectiveness; observational data leave open randomized trials for high-risk subgroups.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tarride et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: